In a crossover RCT of 17 mildly hypercholesterolemic postmenopausal women, five-week diets enriched in stearic acid (18:0) or oleic acid (18:1) produced strikingly similar hepatic effects compared to palmitic acid (16:0): fasting total primary bile acids fell by roughly 159–200 µmol/L, FXR and SHP gene expression rose 3–4 fold, and the cholesterol synthesis-to-absorption ratio dropped 22–24%. Stearic acid additionally showed a unique signature — lower fecal secondary bile acids versus oleic acid and higher non-fasting conjugated bile acids versus palmitic — suggesting distinct enterohepatic recycling dynamics, though gut microbiome diversity was largely stable across all three diets.
The finding matters because the long-standing puzzle of why a saturated fat behaves like a monounsaturated fat now has a mechanistic answer: both stearic and oleic acids appear to activate the FXR-SHP hepatic feedback axis that suppresses cholesterol synthesis and modifies bile acid pools, bypassing the LDL-raising pathway triggered by palmitic acid. This has practical dietary implications — foods high in stearic acid (dark chocolate, beef tallow, cocoa butter) may be genuinely distinct from palmitic-heavy foods (palm oil, dairy fat) in cardiovascular risk terms. Key limitations are the very small sample (n=17), single demographic (postmenopausal women), and secondary-analysis status, meaning these mechanistic findings are exploratory rather than confirmatory. Replication in larger, more diverse populations is essential before clinical guidance changes. Still, the multi-omics correlations (r = 0.43–0.72) linking microbes, bile acids, gene expression, and lipid profiles are unusually coherent for a study this size — an incremental but genuinely illuminating contribution.
